Scientific Program - Saturday 13 April

Print
Please see below the CODHy Scientific Program.
Please click on the appropriate day to view the relevant program.
 
Friday 12 April, 2019   Saturday 13 April, 2019
 
Saturday 13 April, 2019
 
HALL A
09:15-10:00
Plenary 9 | Key Note Lecture
Chairs:
Ofri Mosenzon, Israel and Guang Ning, China
09:15-19:45
New guidelines in diabetes: Stefano Del Prato, Italy
09:45-10:00
Discussion
 
HALL A
10:00-11:30
Session 10 | Diabetes
Chairs:
Naim Shehadeh, Israel and Weiqing Wang, China
 
Vascular complication in LADA similar or different from T2D?
10:00-10:10
More microangiopathy? Raffaella Buzzetti, Italy
10:10-10:20
More macropangiopathy? Ernesto Maddaloni, Italy
10:20-10:25
Q&A
10:25-10:27
Debate summary: Raffaella Buzzetti, Italy
10:27-10:30
Vote Yes/No
 
Should we turn to new therapies in diabetes despite the cost?
10:30-10:40
Yes: Arnon Afek, Israel
10:40-10:50
No: Guang Ning, China
10:50-10:55
Q&A
10:55-10:57
Debate summary: Arnon Afek, Israel
10:57-11:00
Vote Yes/No
11:00-11:20
Has pancreatic islet transplantation failed clinical expectations? Naim Shehadeh, Israel
11:20-11:27
Discussion
11:27-11:30
Vote Yes/No
 
HALL A
11:30-12:00
VISIT EXHIBITS & COFFEE BREAK
12:00-13:00
Session 11 | Rising Stars Present Controversial Cases and Oral Presentations
Chairs:
Stefano Del Prato, Italy  and Itamar Raz, Israel
12:00-12:10
Vascular risk in LADA – An ongoing controversy: Ernesto Maddaloni, Italy
12:10-12:20
Individual level lifestyle intervention: is it the “magic pill” to prevent T2D? Luohua Jiang, USA
12:20-12:30
Diets of different composition for treatment of type 2 diabetes: Giovanni Antonio Silverii, Italy
12:30-12:40
Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome: Ilaria Cavallari, Italy


12:40-13:00
Conclusions and Winners announcement by chairs
13:00-14:00
VISIT EXHIBITS & LUNCH
 
HALL A
14:00-15:00
Session 12 | Diabetes and Obesity
Chairs:
Antonio Ceriello, Italy and Eberhard Standl, Germany
 
Should we consider metabolic bariatric surgery at the early diagnosis of diabetes?
14:00-14:10
Yes: Luc Van Gaal, Belgium
14:10-14:20
No: Ernesto Maddaloni, Italy
14:20-14:25
Q&A
14:25-14:27
Debate summary: Antonio Ceriello, Italy
14:27-14:30
Vote Yes/No
14:30-14:50
Will dual agonists (GLP1/Glucagon) provide the pharmacologic treatment for obesity and diabetes? Roy Eldor, Israel
14:50-14:57
Discussion
14:57:15:00
Vote Yes/No
 
HALL A
15:00-16:30
Session 13 | Diabetes
Chairs:
Stefano Del Prato, Italy and Itamar Raz, Israel
 
Should T2D patient without clinical HF be treated first by SGLT2?
15:00-15:10
Yes: Simona Cernea, Romania
15:10-15:20
No: Stefano Del Prato, Italy
15:20-15:25
Q&A
15:25-15:27
Debate summary: Simona Cernea, Romania
15:27-15:30
Vote Yes/No
 
Should T2D patient with "normal" kidney function be treated first with SGLT2?
15:30-15:40
Yes: Itamar Raz, Israel
15:40-15:50
No: Antonio Ceriello, Italy
15:50-15:55
Q&A
15:55-15:57
Debate summary: Eberhard Standl, Germany
15:57-16:00
Vote Yes/No
 
Hyperglycemia in T2D is a big issue
16:00-16:10
Yes: Eberhard Standl, Germany
16:10-16:20
No: Paolo Pozzilli, Italy
16:20-16:25
Q&A
16:25-16:27
Debate summary: Stefano Del Prato, Italy
16:27-16:30
Vote Yes/No
16:30-16:35
Closing remarks by CODHy Chairs: Stefano Del Prato, Italy and Itamar Raz, Israel
16:35-17:00
FAREWELL RECEPTION
END OF DAY 2